Solid Biosciences Inc.SLDBNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank80
3Y CAGR-5.3%
5Y CAGR+6.4%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-5.3%/yr
vs +14.0%/yr prior
5Y CAGR
+6.4%/yr
Recent deceleration
Acceleration
-19.3pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$180.01M+31.2%
2024$137.25M+8.5%
2023$126.48M-40.2%
2022$211.67M+1.7%
2021$208.21M+57.6%
2020$132.09M+65.0%
2019$80.05M-36.1%
2018$125.18M+311.3%
2017$-59.26M+29.8%
2016$-84.36M-